Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'OLOMOUCINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 44 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sielecki, TM; Johnson, TL; Liu, J; Muckelbauer, JK; Grafstrom, RH; Cox, S; Boylan, J; Burton, CR; Chen, HY; Smallwood, A; Chang, CH; Boisclair, M; Benfield, PA; Trainor, GL; Seitz, SP
      Quinazolines as cyclin dependent kinase inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    2. Milton, NGN
      Phosphorylation of amyloid-beta at the serine 26 residue by human cdc2 kinase

      NEUROREPORT
    3. Furet, P; Meyer, T; Mittl, P; Fretz, H
      Identification of cylin-dependent kinase 1 inhibitors of a new chemical type by structure-based design and database searching

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    4. Chmela, Z; Vesely, J; Lemr, K; Rypka, M; Hanus, J; Havlicek, L; Drystof, V; Michnova, L; Fuksova, K; Lukes, J
      In vivo metabolism of 2,6,9-trisubstituted purine-derived cyclin-dependentkinase inhibitor bohemine in mice: Glucosidation as the principal metabolic route

      DRUG METABOLISM AND DISPOSITION
    5. Temmerman, W; Ritsema, T; Simon-Mateo, C; Van Montagu, M; Mironov, V; Inze, D; Goethals, K; Holsters, M
      The fas locus of the phytopathogen Rhodococcus fascians affects mitosis oftobacco BY-2 cells

      FEBS LETTERS
    6. Harmse, L; van Zyl, R; Gray, N; Schultz, P; Leclerc, S; Meijer, L; Doerig, C; Havlik, I
      Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum

      BIOCHEMICAL PHARMACOLOGY
    7. Atienza, C; Elliott, MJ; Dong, YB; Yang, HL; Stilwell, A; Liu, TJ; McMasters, KM
      Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    8. Corellou, F; Bisgrove, SR; Kropf, DL; Meijer, L; Kloareg, B; Bouget, FY
      A S/M DNA replication checkpoint prevents nuclear and cytoplasmic events of cell division including centrosomal axis alignment and inhibits activation of cyclin-dependent kinase-like proteins in fucoid zygotes

      DEVELOPMENT
    9. Furet, P; Zimmermann, J; Capraro, HG; Meyer, T; Imbach, P
      Structure-based design of potent CDK1 inhibitors derived from olomoucine

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    10. Chen, F; Rao, J; Studzinski, GP
      Specific association of increased cyclin-dependent kinase 5 expression with monocytic lineage of differentiation of human leukemia HL60 cells

      JOURNAL OF LEUKOCYTE BIOLOGY
    11. Travnicek, Z; Malon, M; Biler, M; Hajduch, M; Broz, P; Dolezal, K; Holub, J; Krystof, V; Strnad, M
      Synthesis, characterization and biological activity of two nickel(II) complexes with 6-(2-chlorobenzylamino)purine

      TRANSITION METAL CHEMISTRY
    12. Waters, NC; Woodard, CL; Prigge, ST
      Cyclin H activation and drug susceptibility of the Pfmrk cyclin dependent protein kinase from Plasmodium falciparum

      MOLECULAR AND BIOCHEMICAL PARASITOLOGY
    13. Kim, KS; Sack, JS; Tokarski, JS; Qian, LG; Chao, ST; Leith, L; Kelly, YF; Misra, RN; Hunt, JT; Kimball, SD; Humphreys, WG; Wautlet, BS; Mulheron, JG; Webster, KR
      Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: Synthesis and biological effects

      JOURNAL OF MEDICINAL CHEMISTRY
    14. Otyepka, M; Krystof, V; Havlicek, L; Siglerova, V; Strnad, M; Koca, J
      Docking-based development of purine-like inhibitors of cyclin-dependent kinase-2

      JOURNAL OF MEDICINAL CHEMISTRY
    15. Chang, YT; Gray, NS; Rosania, GR; Sutherlin, DP; Kwon, S; Norman, TC; Sarohia, R; Leost, M; Meijer, L; Schultz, PG
      Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors

      CHEMISTRY & BIOLOGY
    16. LEE J; HATA K; MIYANO T; YAMASHITA M; DAI YF; MOOR RM
      TYROSINE PHOSPHORYLATION OF P34(CDC2) IN METAPHASE II-ARRESTED PIG OOCYTES RESULTS IN PRONUCLEUS FORMATION WITHOUT CHROMOSOME SEGREGATION

      Molecular reproduction and development
    17. Legraverend, M; Ludwig, O; Bisagni, E; Leclerc, S; Meijer, L; Giocanti, N; Sadri, R; Favaudon, V
      Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY
    18. Imbach, P; Capraro, HG; Furet, P; Mett, H; Meyer, T; Zimmermann, J
      2,6,9-trisubstituted purines: Optimization towards highly potent and selective CDK1 inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    19. Guillier, F; Roussel, P; Moser, H; Kane, P; Bradley, M
      Solid-phase synthesis of 2,4,6-triaminopyrimidines

      CHEMISTRY-A EUROPEAN JOURNAL
    20. Oh, CH; Lee, SC; Lee, KS; Woo, ER; Hong, CY; Yang, BS; Baek, DJ; Cho, JH
      Synthesis and biological activities of C-2, N-9 substituted 6-benzylaminopurine derivatives as cyclin-dependent kinase inhibitor

      ARCHIV DER PHARMAZIE
    21. Bossenmeyer-Pourie, C; Chihab, R; Schroeder, H; Daval, JL
      Transient hypoxia may lead to neuronal proliferation in the developing mammalian brain: From apoptosis to cell cycle completion

      NEUROSCIENCE
    22. Papazisis, KT; Geromichalos, GD; Kouretas, D; Dimitriadis, KA; Kortsaris, AH
      CDK-inhibitor olomoucine inhibits cell death after exposure of cell lines to cytosine-arabinoside

      CANCER LETTERS
    23. Sankrithi, N; Eskin, A
      Effects of cyclin-dependent kinase inhibitors on transcription and ocular circadian rhythm of Aplysia

      JOURNAL OF NEUROCHEMISTRY
    24. Nakayama, T; Goshima, Y; Misu, Y; Kato, T
      Role of cdk5 and tau phosphorylation in heterotrimeric G protein-mediated retinal growth cone collapse

      JOURNAL OF NEUROBIOLOGY
    25. Hsu, SL; Yin, SC; Liu, MC; Reichert, U; Ho, WL
      Involvement of cyclin-dependent kinase activities in CD437-induced apoptosis

      EXPERIMENTAL CELL RESEARCH
    26. Fan, SJ; Duba, DE; O'Connor, PM
      Cellular effects of olomoucine in human lymphoma cells differing in p53 function

      CHEMOTHERAPY
    27. Kent, LL; Hull-Campbell, NE; Lau, T; Wu, JC; Thompson, SA; Nori, M
      Characterization of novel inhibitors of cyclin-dependent kinases

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    28. WANG ZL; CANAGARAJAH BJ; BOEHM JC; KASSISA S; COBB MH; YOUNG PR; ABDELMEGUID S; ADAMS JL; GOLDSMITH EJ
      STRUCTURAL BASIS OF INHIBITOR SELECTIVITY IN MAP KINASES

      Structure
    29. SASAKI S; HASHIMOTO T; OBANA N; YASUDA H; UEHARA Y; MAEDA A
      DESIGN OF NEW INHIBITORS FOR CDC2 KINASE BASED ON A MULTIPLE PSEUDOSUBSTRATE STRUCTURE

      Bioorganic & medicinal chemistry letters
    30. RATNER N; BLOOM GS; BRADY ST
      A ROLE FOR CYCLIN-DEPENDENT KINASE(S) IN THE MODULATION OF FAST ANTEROGRADE AXONAL-TRANSPORT - EFFECTS DEFINED BY OLOMOUCINE AND THE APC TUMOR-SUPPRESSOR PROTEIN

      The Journal of neuroscience
    31. MAAS JW; HORSTMANN S; BORASIO GD; ANNESER JMH; SHOOTER EM; KAHLE PJ
      APOPTOSIS OF CENTRAL AND PERIPHERAL NEURONS CAN BE PREVENTED WITH CYCLIN-DEPENDENT KINASE MITOGEN-ACTIVATED PROTEIN-KINASE INHIBITORS

      Journal of neurochemistry
    32. Alessi, F; Quarta, S; Savio, M; Riva, F; Rossi, L; Stivala, LA; Scovassi, AI; Meijer, L; Prosperi, E
      The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity

      EXPERIMENTAL CELL RESEARCH
    33. PLANCHAIS S; GLAB N; TREHIN C; PERENNES C; BUREAU JM; MEIJER L; BERGOUNIOUX C
      ROSCOVITINE, A NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR, CHARACTERIZESRESTRICTION POINT AND G2 M TRANSITION IN TOBACCO BY-2 CELL-SUSPENSION/

      Plant journal
    34. BUQUETFAGOT C; LALLEMAND F; MONTAGNE MN; MESTER J
      EFFECTS OF OLOMOUCINE, A SELECTIVE INHIBITOR OF CYCLIN-DEPENDENT KINASES, ON CELL-CYCLE PROGRESSION IN HUMAN CANCER CELL-LINES

      Anti-cancer drugs
    35. HAJDUCH M; KOLAR Z; NOVOTNY R; HANUS J; MIHAL V; HLOBILKOVA A; NOSKOVA V; STRNAD M
      INDUCTION OF APOPTOSIS AND REGRESSION OF SPONTANEOUS DOG MELANOMA FOLLOWING IN-VIVO APPLICATION OF SYNTHETIC CYCLIN-DEPENDENT KINASE INHIBITOR OLOMOUCINE

      Anti-cancer drugs
    36. HOWELL B; ODDE DJ; CASSIMERIS L
      KINASE AND PHOSPHATASE INHIBITORS CAUSE RAPID ALTERATIONS IN MICROTUBULE DYNAMIC INSTABILITY IN LIVING CELLS

      Cell motility and the cytoskeleton
    37. KRUCHER NA; MEIJER L; ROBERTS MH
      THE CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS, OLOMOUCINE AND ROSCOVITINE, ALTER THE EXPRESSION OF A MOLLUSCAN CIRCADIAN PACEMAKER

      Cellular and molecular neurobiology
    38. ISEKI H; KO TC; XUE XY; SEAPAN A; HELLMICH MR; TOWNSEND CM
      CYCLIN-DEPENDENT KINASE INHIBITORS BLOCK PROLIFERATION OF HUMAN GASTRIC-CANCER CELLS

      Surgery
    39. DEAZEVEDO WF; LECLERC S; MEIJER L; HAVLICEK L; STRNAD M; KIM SH
      INHIBITION OF CYCLIN-DEPENDENT KINASES BY PURINE ANALOGS - CRYSTAL-STRUCTURE OF HUMAN CDK2 COMPLEXED WITH ROSCOVITINE

      European journal of biochemistry
    40. REDIG P; SHAUL O; INZE D; VANMONTAGU M; VANONCKELEN H
      LEVELS OF ENDOGENOUS CYTOKININS, INDOLE-3-ACETIC-ACID AND ABSCISIC-ACID DURING THE CELL-CYCLE OF SYNCHRONIZED TOBACCO BY-2 CELLS

      FEBS letters
    41. ABRAHAM RT; ACQUARONE M; ANDERSEN A; ASENSI A; BELLE R; BERGER F; BERGOUNIOUX C; BRUNN G; BUQUETFAGOT C; FAGOT D; GLAB N; GOUDEAU H; GOUDEAU M; GUERRIER P; HOUGHTON P; HENDRIKS H; KLOAREG B; LIPPAI M; MARIE D; MARO B; MEIJER L; MESTER J; MULNERLORILLON O; POULET SA; SCHIERENBERG E; SCHUTTE B; VAULOT D; VERLHAC MH
      CELLULAR EFFECTS OF OLOMOUCINE, AN INHIBITOR OF CYCLIN-DEPENDENT KINASES

      Biology of the cell
    42. ONGKEKO W; FERGUSON DJP; HARRIS AL; NORBURY C
      INACTIVATION OF CDC2 INCREASES THE LEVEL OF APOPTOSIS INDUCED BY DNA-DAMAGE

      Journal of Cell Science
    43. MISTELI T; WARREN G
      MITOTIC DISASSEMBLY OF THE GOLGI-APPARATUS IN-VIVO

      Journal of Cell Science
    44. GLAB N; LABIDI B; QIN LX; TREHIN C; BERGOUNIOUX C; MEIJER L
      OLOMOUCINE, AN INHIBITOR OF THE CDC2 CDK2 KINASES ACTIVITY, BLOCKS PLANT-CELLS AT THE G1 TO S AND G2 TO M CELL-CYCLE TRANSITIONS/

      FEBS letters


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/21 alle ore 12:08:08